comparemela.com

Latest Breaking News On - Lupin limited stock exchange - Page 1 : comparemela.com

Lupin : June 21, 2023 Lupin Receives Approval from U S FDA for Tiotropium Dry Powder Inhaler

Mumbai, Baltimore, June21, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | June 21, 2023

United statesSouth africaVinita guptaShweta munjalAsia pacificLupin limitedBoehringer ingelheim pharmaceuticals incBoehringer ingelheim international gmbCorporate communicationsDrug administrationBiotechnology pharmaceuticalsUnited states foodAbbreviated new drug applicationTiotropium bromide inhalation powderBoehringer ingelheim pharmaceuticalsBromide inhalation powder

Lupin : June 21, 2023 Lupin Receives Approval from U S FDA for Tiotropium Dry PowderInhaler

Mumbai, Baltimore, June21, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | June 21, 2023

South africaUnited statesAsia pacificVinita guptaShweta munjalBoehringer ingelheim pharmaceuticals incLupin limitedCorporate communicationsBoehringer ingelheim international gmbBiotechnology pharmaceuticalsDrug administrationUnited states foodAbbreviated new drug applicationTiotropium bromide inhalation powderBoehringer ingelheim pharmaceuticalsBromide inhalation powder

Lupin : June 20, 2023 Lupin Signs MoU with Government of Maharashtra to Combat Rising Prevalence of Cardiovascular Diseases and COPD

Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services Mumbai, June 20, 2023:Lupin Human Welfare. | June 20, 2023

South africaAsia pacificTushara shankarNagnath mudamNilesh guptaLupin human welfare research foundationDirectorate of health servicesBiotechnology pharmaceuticalsResearch foundationInfrastructure developmentPublic health departmentLupin human welfareCorporate social responsibilityLupin limitedCardiovascular diseasesChronic obstructive pulmonary disease

Lupin : June 3, 2023 Lupin Launches Darunavir Tablets in the United States

Mumbai, Baltimore, June 03, 2023: Global pharma major Lupin Limited today announced the launch of Darunavir Tablets 600 mg and 800 mg to market a generic equivalent of Prezista®. | June 3, 2023

South africaAsia pacificShweta munjalCorporate communicationsJanssen sciences ireland unlimited companyLupin limitedBiotechnology pharmaceuticalsDarunavir tabletsJanssen productsLatin americaMiddle eastGreat placeGlobal headJanssen sciences ireland unlimitedLupin limited stock exchangePress release

Lupin : June 1, 2023 Lupin Receives Approval from U S FDA for Diazepam Rectal Gel

Mumbai, Baltimore, June01, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has. | June 1, 2023

South africaUnited statesNew jerseyAsia pacificShweta munjalNovel laboratories incBausch health companies incDrug administrationBausch healthBiotechnology pharmaceuticalsCorporate communicationsLupin limitedUnited states foodAbbreviated new drug applicationDiazepam rectal gelRectal delivery system

vimarsana © 2020. All Rights Reserved.